Susan L. Solomon, Photo courtesy of NYSCF We were saddened to learn that Susan Solomon, CEO and co‑founder of the New York Stem Cell Foundation, has died. As CEO, she raised more than $400 million for stem cell research, helping catalyze the field and shape the future of medical science. The foundation announced her passing … Continue reading Mourning the death of Susan Solomon
diabetes
A big deal for type 1 diabetes
You don’t often get excited about company mergers. That changed with today’s deal, especially if you have type 1 diabetes (T1D). The announcement Today, Vertex announced it is buying ViaCyte for $320 million in cash. This matters because both companies are developing stem cell therapies for people with T1D. Combining their efforts may speed up … Continue reading A big deal for type 1 diabetes
CIRM Approves Funding for Rare Immune Disorder
Taylor Lookofsky (center), a person with IPEX syndrome, with his father Brian and Dr. Rosa Bacchetta IPEX syndrome is a rare condition where the body can’t control or restrain an immune response, so the person’s immune cells attack their own healthy tissue. The syndrome mostly affects boys, is diagnosed in the first year of life, … Continue reading CIRM Approves Funding for Rare Immune Disorder
Two Early-Stage Research Programs Targeting Cartilage Damage Get Funding from Stem Cell Agency
Darryl D'Lima: Scripps Health Every year, millions of Americans damage cartilage in their knees and other joints. These injuries can lead to osteoarthritis, pain, and loss of mobility. Today, the CIRM Board approved two projects to repair damaged cartilage. The projects were among 17 awards approved through CIRM’s DISC2 Quest Discovery Program. The program supports … Continue reading Two Early-Stage Research Programs Targeting Cartilage Damage Get Funding from Stem Cell Agency
Producing insulin for people who can’t
ViaCyte's implantable stem cell pouch One of CIRM's greatest strengths is supporting projects throughout the development process. Many promising ideas begin in the laboratory. Few advance to human clinical trials. CIRM helps bridge that gap by supporting research from early discovery through clinical testing. A recent announcement from ViaCyte highlights the value of that approach. … Continue reading Producing insulin for people who can’t
Exploring New Stem Cell Therapies for Type 1 Diabetes
Type 1 diabetes (T1D) affects millions of people and requires constant attention. For patients and families, managing the disease can be physically and emotionally demanding. People with T1D must carefully monitor their blood sugar levels throughout the day. They must also balance meals, activity levels, and insulin doses to keep glucose within a healthy range. … Continue reading Exploring New Stem Cell Therapies for Type 1 Diabetes
National Academy of Medicine honors CIRM Grantees
As someone who doesn’t always send birthday cards on time, I’m used to offering belated congratulations. So I have no shame in sending them now to four CIRM grantees elected to the National Academy of Medicine in 2020. I say four, but it’s really three and a half. I’ll explain why in a moment. Being … Continue reading National Academy of Medicine honors CIRM Grantees
Creating a better way to treat type 1 diabetes
LISTEN TO THIS BLOG AS AN AUDIOCAST ON SPOTIFY The cell encapsulation device (right) that is being developed by Encellin, a San Francisco–based biotechnology company. Photo courtesy of Encellin Type 1 diabetes (t1d) affects every aspect of a person’s life, from what they eat and when they eat, to when they exercise and how they feel … Continue reading Creating a better way to treat type 1 diabetes
Stem Cell Therapy Shows Promise for Diabetic Foot Ulcers
Diabetes can affect nearly every part of the body. Over time, uncontrolled blood sugar levels can damage blood vessels and nerves, leading to serious complications. One of the most challenging is the diabetic foot ulcer (DFU), an open wound that typically develops on the foot. Poor circulation and nerve damage often make these wounds difficult … Continue reading Stem Cell Therapy Shows Promise for Diabetic Foot Ulcers
UCSF Nursing Professor Joins CIRM Board
Elena Flowers, PhD, RN, newest member of the CIRM Board: Photo courtesy UCSF Elena Flowers, PhD, RN, an associate professor of physiological nursing at the University of California, San Francisco (UCSF) is joining the Board of the California Institute for Regenerative Medicine (CIRM), the state’s Stem Cell Agency. Dr. Flowers was appointed to the Board … Continue reading UCSF Nursing Professor Joins CIRM Board